Vertex Pharmaceuticals VRTX was a big mover last session, as its shares rose almost 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday’s rally reverses the downtrend for the company since Dec 29, as the stock is now down almost 19%.
Over the last 30 days, the company witnessed one positive estimate revision and the Zacks Consensus Estimate also moved higher, suggesting solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
Vertex Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.
A better-ranked biomedical stock is Acorda Therapeutics, Inc. ACOR with a Zacks Rank #1 (Strong Buy).
Is VRTX going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.
Click to get this free report VERTEX PHARM (VRTX): Free Stock Analysis Report ACORDA THERAPT (ACOR): Free Stock Analysis Report To read this article on Zacks.com click here.